Cargando…
Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma
Glioblastoma remains one of the deadliest of human cancers, with most patients succumbing to the disease within two years of diagnosis. The available data suggest that simultaneous inactivation of critical nodes within the glioblastoma molecular circuitry will be required for meaningful clinical eff...
Autores principales: | Li, Jie, Zhu, Shan, Kozono, David, Ng, Kimberly, Futalan, Diahnn, Shen, Ying, Akers, Johnny C., Steed, Tyler, Kushwaha, Deepa, Schlabach, Michael, Carter, Bob S., Kwon, Chang-Hyuk, Furnari, Frank, Cavenee, Webster, Elledge, Stephen, Chen, Clark C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011590/ https://www.ncbi.nlm.nih.gov/pubmed/24658464 |
Ejemplares similares
-
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas
por: Kushwaha, Deepa, et al.
Publicado: (2014) -
Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition
por: Shen, Ying, et al.
Publicado: (2015) -
Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations
por: Wykosky, Jill, et al.
Publicado: (2011) -
Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010) -
Optimized PCR Conditions and Increased shRNA Fold Representation Improve Reproducibility of Pooled shRNA Screens
por: Strezoska, Žaklina, et al.
Publicado: (2012)